NATCO PHARMA LTD. Share Price, Financial Results, Charts & Analysis

NATCO PHARMA LTD. (NATCOPHARM)

NSE: ₹918.70

BSE: ₹918.90

Corporate Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Earning call Transcript for the concall held on May 29, 2026

2026-06-04 14:53:24

Announcement under Regulation 30 (LODR)-Press Release / Media Release

NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection

2026-06-03 11:14:03

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Annual Audited Financial Results for the Quarter and Year ended March 31, 2026

2026-05-30 12:22:32

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio Link of Concall held on May 29, 2026

2026-05-30 12:18:31

Announcement under Regulation 30 (LODR)-Investor Presentation

FY26 Earnings Call Investor Presentation

2026-05-29 15:34:05

Particulars	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue from Operations	1,140.50	1,031.40	758.60	1,068.30	1,362.60	1,371.10	474.80	1,221.00	1,328.90	1,363.00	647.30	739.10
YOY Revenue Growth %	28.93%	138.69%	54.03%	18.98%	19.47%	32.94%	-37.41%	14.29%	-2.47%	-0.59%	36.33%	-39.47%
Other Income	19.70	29.40	37.00	42.00	48.10	63.80	176.30	66.30	61.70	100.00	58.10	77.80
Total Income	1,160.20	1,060.80	795.60	1,110.30	1,410.70	1,434.90	651.10	1,287.30	1,390.60	1,463.00	705.40	816.90
Total Expenses +	660.20	621.20	539.30	632.70	607.10	616.70	487.40	781.40	818.70	849.30	544.30	672.80
Cost of Materials Consumed	136.20	166.50	92.20	127.60	151.30	143.20	72.70	169.00	180.60	174.90	135.20	102.80
Employee Benefit Expense	138.20	122.40	121.90	142.50	142.00	151.50	141.60	159.40	169.00	200.30	159.40	158.50
Other Expenses	278.30	235.20	206.40	285.90	235.60	237.70	211.60	264.30	355.90	413.80	196.10	298.30
Operating Profit	480.30	410.20	219.30	435.60	755.50	754.40	-12.60	439.60	510.20	513.70	103.00	66.30
OPM %	42.1%	39.8%	28.9%	40.8%	55.4%	55%	-2.7%	36%	38.4%	37.7%	15.9%	9%
Profit Before Tax +	500.00	439.60	256.30	477.60	803.60	818.20	163.70	505.90	571.90	613.70	161.10	144.10
Tax Expense	79.70	70.60	43.60	91.30	135.10	141.70	31.30	99.90	91.60	95.80	9.80	-124.90
Tax %	15.9%	16.1%	17%	19.1%	16.8%	17.3%	19.1%	19.7%	16%	15.6%	6.1%	-86.7%
Profit After Tax	420.30	369.00	212.70	386.30	668.50	676.50	132.40	406.00	480.30	517.90	151.30	269.00
EPS (Basic)	23.26	20.60	11.88	21.56	37.32	37.81	7.43	22.70	26.84	28.94	8.46	14.96

Particulars

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Revenue from Operations

1,140.50

1,031.40

758.60

1,068.30

1,362.60

1,371.10

474.80

1,221.00

1,328.90

1,363.00

647.30

739.10

YOY Revenue Growth %

28.93%

138.69%

54.03%

18.98%

19.47%

32.94%

-37.41%

14.29%

-2.47%

-0.59%

36.33%

-39.47%

Other Income

19.70

29.40

37.00

42.00

48.10

63.80

176.30

66.30

61.70

100.00

58.10

77.80

Total Income

1,160.20

1,060.80

795.60

1,110.30

1,410.70

1,434.90

651.10

1,287.30

1,390.60

1,463.00

705.40

816.90

Total Expenses +

660.20

621.20

539.30

632.70

607.10

616.70

487.40

781.40

818.70

849.30

544.30

672.80

Cost of Materials Consumed

136.20

166.50

92.20

127.60

151.30

143.20

72.70

169.00

180.60

174.90

135.20

102.80

Employee Benefit Expense

138.20

122.40

121.90

142.50

142.00

151.50

141.60

159.40

169.00

200.30

159.40

158.50

Other Expenses

278.30

235.20

206.40

285.90

235.60

237.70

211.60

264.30

355.90

413.80

196.10

298.30

Operating Profit

480.30

410.20

219.30

435.60

755.50

754.40

-12.60

439.60

510.20

513.70

103.00

66.30

OPM %

42.1%

39.8%

28.9%

40.8%

55.4%

55%

-2.7%

36%

38.4%

37.7%

15.9%

Profit Before Tax +

500.00

439.60

256.30

477.60

803.60

818.20

163.70

505.90

571.90

613.70

161.10

144.10

Tax Expense

79.70

70.60

43.60

91.30

135.10

141.70

31.30

99.90

91.60

95.80

9.80

-124.90

Tax %

15.9%

16.1%

17%

19.1%

16.8%

17.3%

19.1%

19.7%

16%

15.6%

6.1%

-86.7%

Profit After Tax

420.30

369.00

212.70

386.30

668.50

676.50

132.40

406.00

480.30

517.90

151.30

269.00

EPS (Basic)

23.26

20.60

11.88

21.56

37.32

37.81

7.43

22.70

26.84

28.94

8.46

14.96

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue from Operations	4,078.30	4,429.50	3,998.80	2,707.10	1,944.80	2,052.10	1,915.00
YOY Revenue Growth %	-7.93%	10.77%	47.72%	39.2%	-5.23%	7.16%	-
Other Income	297.60	354.50	128.10	104.60	99.00	103.60	107.40
Total Income	4,375.90	4,784.00	4,126.90	2,811.70	2,043.80	2,155.70	2,022.40
Total Expenses +	2,885.10	2,492.60	2,453.40	1,949.80	1,841.60	1,576.10	1,279.80
Cost of Materials Consumed	593.50	536.20	522.50	475.30	519.20	372.90	329.00
Employee Benefit Expense	687.20	594.50	525.00	486.70	444.80	414.90	375.00
Other Expenses	1,264.10	949.20	1,005.80	657.50	675.60	519.60	575.80
Operating Profit	1,193.20	1,936.90	1,545.40	757.30	103.20	476.00	635.20
OPM %	29.3%	43.7%	38.6%	28%	5.3%	23.2%	33.2%
Profit Before Exceptional	1,490.80	2,291.40	1,673.50	861.90	202.20	579.60	568.70
Exceptional Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax +	1,490.80	2,291.40	1,673.50	861.90	202.20	579.60	568.70
Tax Expense	72.30	408.00	285.20	146.60	32.20	137.20	110.60
Tax %	4.8%	17.8%	17%	17%	15.9%	23.7%	19.4%
Profit After Tax	1,418.50	1,883.40	1,388.30	715.30	170.00	442.40	458.10
EPS (Basic)	79.20	105.26	77.34	39.18	9.32	24.20	25.33

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Revenue from Operations

4,078.30

4,429.50

3,998.80

2,707.10

1,944.80

2,052.10

1,915.00

YOY Revenue Growth %

-7.93%

10.77%

47.72%

39.2%

-5.23%

7.16%

Other Income

297.60

354.50

128.10

104.60

99.00

103.60

107.40

Total Income

4,375.90

4,784.00

4,126.90

2,811.70

2,043.80

2,155.70

2,022.40

Total Expenses +

2,885.10

2,492.60

2,453.40

1,949.80

1,841.60

1,576.10

1,279.80

Cost of Materials Consumed

593.50

536.20

522.50

475.30

519.20

372.90

329.00

Employee Benefit Expense

687.20

594.50

525.00

486.70

444.80

414.90

375.00

Other Expenses

1,264.10

949.20

1,005.80

657.50

675.60

519.60

575.80

Operating Profit

1,193.20

1,936.90

1,545.40

757.30

103.20

476.00

635.20

OPM %

29.3%

43.7%

38.6%

28%

5.3%

23.2%

33.2%

Profit Before Exceptional

1,490.80

2,291.40

1,673.50

861.90

202.20

579.60

568.70

Exceptional Items

0.00

Profit Before Tax +

1,490.80

2,291.40

1,673.50

861.90

202.20

579.60

568.70

Tax Expense

72.30

408.00

285.20

146.60

32.20

137.20

110.60

Tax %

4.8%

17.8%

17%

15.9%

23.7%

19.4%

Profit After Tax

1,418.50

1,883.40

1,388.30

715.30

170.00

442.40

458.10

EPS (Basic)

79.20

105.26

77.34

39.18

9.32

24.20

25.33

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
ASSETS
Non-Current Assets +	6,021.40	3,360.80	2,882.80	2,657.10	2,611.90	2,454.60	0.00
Property, Plant & Equipment	2,545.40	2,431.90	2,297.70	2,239.10	2,178.90	2,013.80	0.00
Capital Work in Progress	293.70	225.40	137.30	64.30	129.50	223.40	0.00
Non-Current Investments	273.20	152.80	95.90	87.30	104.40	159.40	0.00
Goodwill	63.00	57.40	56.00	55.20	50.70	0.00	0.00
Other Intangible Assets	194.30	208.70	137.10	132.60	82.20	9.40	0.00
Current Assets +	5,052.30	5,270.00	4,023.50	3,000.30	2,497.20	2,337.30	0.00
Inventories	908.50	765.80	700.50	742.90	762.00	798.20	0.00
Trade Receivables	881.20	1,246.60	1,188.90	856.10	620.60	412.90	0.00
Cash and Cash Equivalents	198.90	120.00	70.40	131.90	111.10	25.80	0.00
Current Investments	578.20	320.80	443.50	305.00	203.70	144.30	0.00
LIABILITIES & EQUITY
Total Equity	9,221.10	7,612.30	5,853.10	4,873.80	4,263.60	4,123.40	0.00
Equity Share Capital	35.80	35.80	35.80	36.50	36.50	36.50	0.00
Other Equity	9,185.30	7,571.20	5,817.30	4,837.30	4,227.10	4,085.10	0.00
Non-Current Liabilities	171.70	75.00	80.40	100.50	135.10	142.90	0.00
Current Liabilities	1,680.90	943.50	972.80	683.10	710.40	525.60	0.00
Total Liabilities	1,852.60	1,018.50	1,053.20	783.60	845.50	668.50	0.00

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

ASSETS

Non-Current Assets +

6,021.40

3,360.80

2,882.80

2,657.10

2,611.90

2,454.60

0.00

Property, Plant & Equipment

2,545.40

2,431.90

2,297.70

2,239.10

2,178.90

2,013.80

0.00

Capital Work in Progress

293.70

225.40

137.30

64.30

129.50

223.40

0.00

Non-Current Investments

273.20

152.80

95.90

87.30

104.40

159.40

0.00

Goodwill

63.00

57.40

56.00

55.20

50.70

0.00

Other Intangible Assets

194.30

208.70

137.10

132.60

82.20

9.40

0.00

Current Assets +

5,052.30

5,270.00

4,023.50

3,000.30

2,497.20

2,337.30

0.00

Inventories

908.50

765.80

700.50

742.90

762.00

798.20

0.00

Trade Receivables

881.20

1,246.60

1,188.90

856.10

620.60

412.90

0.00

Cash and Cash Equivalents

198.90

120.00

70.40

131.90

111.10

25.80

0.00

Current Investments

578.20

320.80

443.50

305.00

203.70

144.30

0.00

LIABILITIES & EQUITY

Total Equity

9,221.10

7,612.30

5,853.10

4,873.80

4,263.60

4,123.40

0.00

Equity Share Capital

35.80

36.50

0.00

Other Equity

9,185.30

7,571.20

5,817.30

4,837.30

4,227.10

4,085.10

0.00

Non-Current Liabilities

171.70

75.00

80.40

100.50

135.10

142.90

0.00

Current Liabilities

1,680.90

943.50

972.80

683.10

710.40

525.60

0.00

Total Liabilities

1,852.60

1,018.50

1,053.20

783.60

845.50

668.50

0.00

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activities	1,768.30	1,696.80	1,211.60	849.10	46.50	298.80
Cash from Investing Activities	-2,142.90	-1,414.50	-1,032.70	-477.10	-5.30	-103.30
Cash from Financing Activities	297.50	-210.70	-246.90	-363.00	34.80	-185.70
Net Increase/Decrease in Cash	78.90	49.60	-61.50	20.80	85.30	6.00

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Cash from Operating Activities

1,768.30

1,696.80

1,211.60

849.10

46.50

298.80

0.00

Cash from Investing Activities

-2,142.90

-1,414.50

-1,032.70

-477.10

-5.30

-103.30

0.00

Cash from Financing Activities

297.50

-210.70

-246.90

-363.00

34.80

-185.70

0.00

Net Increase/Decrease in Cash

78.90

49.60

-61.50

20.80

85.30

6.00

0.00

NATCO PHARMA LTD. (NATCOPHARM)

Stock Performance

Corporate Announcements

Quarterly Financials

Yearly Financial Results

Balance Sheet

Cash Flow Statement